+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Haemodynamic Monitoring Systems Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163135
The global haemodynamic monitoring systems market was valued at USD 1.11 Billion in 2024 driven by the rising advancements in haemodynamic monitoring systems and the increasing burden of cardiovascular diseases. The market is further expected to grow at a CAGR of 5.20% in the forecast period of 2025-2034 to reach a value of over USD 1.84 Billion by 2034.

Global Haemodynamic Monitoring Systems Market Overview

Hemodynamic monitoring systems are devices that allow for the evaluation and optimisation of haemodynamic parameters and oxygen delivery, which aids in the diagnosis and treatment of a variety of cardiopulmonary disorders and improving outcomes in critically ill patients. Haemodynamic monitoring has progressed over time from simple CO tracking to complex sensors that offer data on a variety of factors, such as blood pressure, blood volume, and fluid balance.

The haemodynamic monitoring systems market share is influenced by the increasing cases of critically ill geriatric patients, the rising prevalence of cardiac disorders, and the surging demand for home-based and non-invasive monitoring systems. The advancements in technology due to funding from private players and government bodies and the increasing prevalence of hypertension are also propelling the market demand. As haemodynamic monitoring systems are primarily used to assess the cardiovascular health, longevity, and quality of life of patients undergoing or recuperating from cardiac surgery, the parameters are measured using photo metrics, electrical, pressure transducing equipment and invasive and non-invasive devices. Thus, the rising burden of cardiovascular diseases is poised to impact the market dynamics.

The haemodynamic monitoring systems market value is also being driven by factors, such as technological advancements, increasing research and development (R&D) activities, an influx of venture capital funding, the rising incidences of surgeries, industry-wide awareness initiatives, and the growing government focus on critical care infrastructure and services. Also, the increasing demand for patient monitoring devices in non-hospital settings and emerging economies is likely to provide lucrative growth possibilities for market competitors.

Global Haemodynamic Monitoring Systems Market Growth Drivers

Increasing Prevalence of Cardiovascular Diseases Impacts Market Landscape

Recent data reveals that cardiovascular disease is the leading cause of mortality for men and women worldwide. Around 620 million people in the world are affected by heart and circulatory disease, which translates to roughly 1 in 13 people living with a heart or circulatory condition . The rising burden of cardiovascular diseases is a significant growth driver of the market as these devices help in continuous haemodynamic monitoring, early diagnosis, and effective management of the cardiovascular condition necessary to prevent complications.

Technological Advancements Set to Fuel Haemodynamic Monitoring Systems Market Demand

In October 2023, Chinese medical device company Mindray Bio-Medical Electronics Co., Ltd's BeneVision N-Series became the first patient monitoring system to integrate the FloTrac sensor (developed by United States-based Edwards Lifesciences) for hemodynamic monitoring, expanding the N-Series capability to monitor patients' hemodynamic condition. This advancement offers a vital tool to healthcare providers for proactively addressing potential declines in a patient's condition and personalizing fluid management strategies. The introduction of such innovative haemodynamic monitoring solutions is expected to bolster the market growth in the forecast period.

Global Haemodynamic Monitoring Systems Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Increasing Surgical Procedures

One of the major market trends is the growth in the number of surgical procedures, particularly those involving cardiac care, which require the use of haemodynamic monitoring systems to ensure optimal patient outcomes. The increasing utilisation of haemodynamic monitoring solutions in perioperative and postoperative care settings is poised to fuel market growth.

Growing Demand for Minimally Invasive Procedures

The market is witnessing an increased demand for minimally invasive haemodynamic monitoring techniques owing to several associated benefits such as the reduced risk of complications, shorter hospital stays, and quicker recovery times. This trend is expected to drive growth and innovation in minimally invasive technology which is likely to boost the haemodynamic monitoring systems market share.

Shift Towards Home Healthcare

The rising shift towards home healthcare and remote patient monitoring is boosting the demand for portable and user-friendly haemodynamic monitoring systems. Continued innovation in developing more accurate and affordable remote monitoring devices with simplified interfaces and automated data transmission features is anticipated to augment the market demand.

Rising Healthcare Expenditure

Governments and healthcare organisations are increasing their expenditure to improve and expand healthcare facilities and services which also influences the adoption of advanced medical technologies such as haemodynamic monitoring systems.

Global Haemodynamic Monitoring Systems Segmentation

The report titled “Haemodynamic Monitoring Systems Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by System

  • Minimally Invasive Monitoring Systems
  • Invasive Monitoring System
  • Non-Invasive Monitoring Systems

Market Breakup by Application

  • Laboratory-Based Monitoring Systems
  • Home-Based Monitoring Systems
  • Hospital-Based Monitoring Systems

Market Breakup by Product

  • Monitors
  • Disposables

Market Breakup by End User

  • Hospitals
  • Clinics and Ambulatory Care Centers
  • Home Care Settings

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Haemodynamic Monitoring Systems Market Share

Market Segmentation Based on System is Anticipated to Witness Substantial Growth

By system, the market is segmented into minimally invasive monitoring systems, invasive monitoring systems, and non-invasive monitoring systems. Minimally invasive monitoring systems hold a significant market share owing to the rising advancements in sensor technology and data analytics that have improved the accuracy and reliability of these devices. These systems are suitable for a broader patient population as they offer less discomfort and shorter recovery times. Moreover, non-invasive monitoring systems are also poised to witness considerable growth driven by increasing demand for patient-friendly monitoring methods, innovations in non-invasive technology, and the rising preference for outpatient and homecare settings.

Global Haemodynamic Monitoring Systems Market Analysis by Region

North America holds a significant share of the market, owing to rapid technological advancements in the region. The rising development of technologically equipped hospitals and the increasing number of critically sick patients treated in countries like the United States and Canada are driving the market demand. As the prevalence of diseases, such as cancer, hyperthermia, and other cardiovascular issues is surging, the use of haemodynamic monitoring systems is significantly increasing, which is fuelling the market growth.

The haemodynamic monitoring systems market is likely to grow over the forecast period because of rising regulatory approvals for monitoring devices and new product releases in the region. The growth can also be attributed to the high prevalence of cardiovascular diseases and diabetes and the increasing product launches. The intensifying competition in the region is leading to the development of innovative haemodynamic monitoring systems, which are further projected to boost the market share. Additionally, the Asia Pacific region is expected to witness robust growth owing to the rising governmental focus on quality healthcare, high demand for monitoring devices from India, China and Japan, and high diabetes prevalence.

Leading Players in the Global Haemodynamic Monitoring Systems Market

The key features of the market report comprise patent analysis, and strategic initiatives such as joint ventures along with partnerships and collaborations by the key players. The major companies in the market are as follows:

Getinge AB

This global provider of medical technology solutions has a prominent presence in the market. Its advanced hemodynamic patient monitoring platform, PulsioFlex, features modular expandability and efficient monitoring technologies.

Edwards Lifesciences

Headquartered in California, Edwards Lifesciences is an American medical technology company specialising in haemodynamic monitoring. It boasts a robust portfolio of advanced hemodynamic monitoring solutions comprising a range of sensors, software, cuffs, and catheters.

Koninklijke Philips N.V.

Technology company Koninklijke Philips N.V. is one of the leading market players and significantly contributes to the haemodynamic monitoring systems market growth. One of its key products is the IntelliVue monitoring system which includes advanced haemodynamic monitoring features integrated into comprehensive patient monitoring solutions.

ICU Medical, Inc.

ICU Medical is a medical device company that is known for its innovative Cogent 2-in-1 hemodynamic monitoring system. Cogent 2-in-1 Hemodynamic Monitoring System is designed to accept both minimally invasive and invasive inputs, allowing healthcare providers to use a single monitor regardless of changes in patient conditions and monitoring requirements.

Other key players in the market include LiDCO Limited, Schwarzer Cardiotek GmbH, OSYPKA MEDICAL, Nihon Kohden Corporation, Deltex Medical Limited, and TELEFLEX INC.

Key Questions Answered in the Global Haemodynamic Monitoring Systems Market Report

  • What was the global haemodynamic monitoring systems market value in 2024?
  • What is the global haemodynamic monitoring systems market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is market segmentation based on the system?
  • What is the market breakup based on application?
  • Who are the major end users in the market?
  • What types of products are present in the market?
  • What are the major factors aiding the global haemodynamic monitoring systems market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • How does the prevalence and incidence of cardiovascular diseases affect the market landscape?
  • What are the major global haemodynamic monitoring systems market trends?
  • How does the rise in the geriatric population impact the market size?
  • Which system will dominate the market share?
  • Which application area is expected to have a high market value in the coming years?
  • Which product type will experience the highest demand in the market segment?
  • Which end user is projected to contribute to the highest market growth?
  • Who are the key players involved in the haemodynamic monitoring systems market?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Haemodynamic Monitoring Systems Market Overview
3.1 Global Haemodynamic Monitoring Systems Market Historical Value (2018-2024)
3.2 Global Haemodynamic Monitoring Systems Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Haemodynamic Monitoring Systems Market Landscape*
5.1 Global Haemodynamic Monitoring Systems: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Haemodynamic Monitoring Systems: Product Landscape
5.2.1 Analysis by System
5.2.2 Analysis by Product
6 Global Haemodynamic Monitoring Systems Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Environmental
6.3.3 Social
6.3.4 Technological
6.3.5 Ethical
6.3.6 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Haemodynamic Monitoring Systems Market Segmentation (2018-2034)
7.1 Global Haemodynamic Monitoring Systems Market (2018-2034) by System
7.1.1 Market Overview
7.1.2 Minimally Invasive Monitoring Systems
7.1.3 Invasive Monitoring System
7.1.4 Non-Invasive Monitoring Systems
7.2 Global Haemodynamic Monitoring Systems Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Laboratory-Based Monitoring Systems
7.2.3 Home-Based Monitoring Systems
7.2.4 Hospital-Based Monitoring Systems
7.3 Global Haemodynamic Monitoring Systems Market (2018-2034) by Product
7.3.1 Market Overview
7.3.2 Monitors
7.3.3 Disposables
7.4 Global Haemodynamic Monitoring Systems Market (2018-2034) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Clinics and Ambulatory Care Centers
7.4.4 Home Care Settings
7.5 Global Haemodynamic Monitoring Systems Market (2018-2034) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Haemodynamic Monitoring Systems Market (2018-2034)
8.1 North America Haemodynamic Monitoring Systems Market (2018-2034) by System
8.1.1 Market Overview
8.1.2 Minimally Invasive Monitoring Systems
8.1.3 Invasive Monitoring System
8.1.4 Non-Invasive Monitoring Systems
8.2 North America Haemodynamic Monitoring Systems Market (2018-2034) by Application
8.2.1 Market Overview
8.2.2 Laboratory-Based Monitoring Systems
8.2.3 Home-Based Monitoring Systems
8.2.4 Hospital-Based Monitoring Systems
8.3 North America Haemodynamic Monitoring Systems Market (2018-2034) by Country
8.3.1 United States of America
8.3.2 Canada
9 Europe Haemodynamic Monitoring Systems Market (2018-2034)
9.1 Europe Haemodynamic Monitoring Systems Market (2018-2034) by System
9.1.1 Market Overview
9.1.2 Minimally Invasive Monitoring Systems
9.1.3 Invasive Monitoring System
9.1.4 Non-Invasive Monitoring Systems
9.2 Services Europe Haemodynamic Monitoring Systems Market (2018-2034) by Application
9.2.1 Market Overview
9.2.2 Laboratory-Based Monitoring Systems
9.2.3 Home-Based Monitoring Systems
9.2.4 Hospital-Based Monitoring Systems
9.3 Europe Haemodynamic Monitoring Systems Market (2018-2034) by Country
9.3.1 United Kingdom
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Others
10 Asia Pacific Haemodynamic Monitoring Systems Market (2018-2034)
10.1 Asia Pacific Haemodynamic Monitoring Systems Market (2018-2034) by System
10.1.1 Market Overview
10.1.2 Minimally Invasive Monitoring Systems
10.1.3 Invasive Monitoring System
10.1.4 Non-Invasive Monitoring Systems
10.2 Asia Pacific Haemodynamic Monitoring Systems Market (2018-2034) by Application
10.2.1 Market Overview
10.2.2 Laboratory-Based Monitoring Systems
10.2.3 Home-Based Monitoring Systems
10.2.4 Hospital-Based Monitoring Systems
10.3 Asia Pacific Haemodynamic Monitoring Systems Market (2018-2034) by Country
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 ASEAN
10.3.5 Australia
10.3.6 Others
11 Latin America Haemodynamic Monitoring Systems Market (2018-2034)
11.1 Latin America Haemodynamic Monitoring Systems Market (2018-2034) by System
11.1.1 Market Overview
11.1.2 Minimally Invasive Monitoring Systems
11.1.3 Invasive Monitoring System
11.1.4 Non-Invasive Monitoring Systems
11.2 Latin America Haemodynamic Monitoring Systems Market (2018-2034) by Application
11.2.1 Market Overview
11.2.2 Laboratory-Based Monitoring Systems
11.2.3 Home-Based Monitoring Systems
11.2.4 Hospital-Based Monitoring Systems
11.3 Latin America Haemodynamic Monitoring Systems Market (2018-2034) by Country
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Mexico
11.3.4 Others
12 Middle East and Africa Haemodynamic Monitoring Systems Market (2018-2034)
12.1 Middle East and Africa Haemodynamic Monitoring Systems Market (2018-2034) by System
12.1.1 Market Overview
12.1.2 Minimally Invasive Monitoring Systems
12.1.3 Invasive Monitoring System
12.1.4 Non-Invasive Monitoring Systems
12.2 Middle East and Africa Haemodynamic Monitoring Systems Market (2018-2034) by Application
12.2.1 Market Overview
12.2.2 Laboratory-Based Monitoring Systems
12.2.3 Home-Based Monitoring Systems
12.2.4 Hospital-Based Monitoring Systems
12.3 Middle East and Africa Haemodynamic Monitoring Systems Market (2018-2034) by Country
12.3.1 Saudi Arabia
12.3.2 United Arab Emirates
12.3.3 Nigeria
12.3.4 South Africa
12.3.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership and Collaborations
15.3 Analysis by Joint Ventures
15.4 Analysis by Leading Players
15.5 Analysis by Geography
16 Supplier Landscape
16.1 Market Share Analysis, By Region (Top 5 Companies)
16.1.1 Market Share Analysis: Global
16.1.2 Market Share Analysis: North America
16.1.3 Market Share Analysis: Europe
16.1.4 Market Share Analysis: Asia-Pacific
16.1.5 Market Share Analysis: Others
16.2 Getinge AB
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Edwards Lifesciences
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Koninklijke Philips N.V.
16.4.1 Product Portfolio
16.4.2 Demographic Reach and Achievements
16.4.3 Mergers and Acquisitions
16.4.4 Certifications
16.5 ICU Medical , Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 LiDCO Limited
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Schwarzer Cardiotek GmbH
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 OSYPKA MEDICAL
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Nihon Kohden Corporation
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Deltex Medical Limited
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 TELEFLEX INC
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Global Haemodynamic Monitoring Systems Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Getinge AB
  • Edwards Lifesciences
  • Koninklijke Philips N.V.
  • ICU Medical, Inc.